Back

ZD100: a novel cyclic GMP activating ANP-based designer peptide in experimental hypertension with structural insights into its unique carboxy-terminus

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Best Posters session 4 - Best Posters in drug therapy and blood pressure lowering Treatment of hypertension ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor John Carlos Burnett Jr

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor K. Dimitriadis (Athens, GR)
Abstract Slides
Presentation thumbnail
Professor K. Rahimi (Oxford, GB)
Abstract
Presentation thumbnail
Doctor L. Papadaki (Athens, GR)
Abstract

Access the full session

Session thumbnail
Best Posters session 4 - Best Posters in drug therapy and blood pressure lowering

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
C-type natriuretic peptide attenuates diastolic dysfunction and cardiac fibrosis in a rat model of heart failure with preserved ejection fraction
28 August 2026
thumbnail
Congress Presentation
The impact of soluble guanylate cyclase stimulator on cardiac and venous return characteristics: a framework analysis using generalized circulatory equilibrium
31 August 2026
thumbnail
Congress Presentation
Cardiovascular and metabolic effects of MANP. a novel GC-A activator, in human hypertension with metabolic syndrome
26 August 2023
thumbnail
Congress Presentation
Acute in vivo antiarrhythmic effects of cGMP-modifying drugs in the R2474S mouse model of catecholiminergic polymorphic ventricular tachycardia.
30 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources